Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

CHP677: I-Metaiodobenzylguanidine (I-MIBG) Therapy for Refractory Neuroblastoma: a Phase II Study

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by:
National Center for Research Resources (NCRR)
ClinicalTrials.gov Identifier:
NCT00013806
First received: March 29, 2001
Last updated: June 23, 2005
Last verified: December 2003
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: No date given